NDRG1 and breast carcinoma: Contrary to the aforementioned studies, a substantial body of research consistently demonstrates that NDRG1 serves as a marker of poor prognosis in patients with breast cancer and functions as a promoter of tumor progression and metastasis in breast cancer models [51,52,53,54,55,56,57,58,59,60,61].